EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders

Muhammad Wasay Shahid iD, Faizur Rehman iD, Mehran Riaz iD, Muhammad Aaqib Akram, Farah Azhar iD, Malik Muhammad Umair iD, Nasim Akhtar iD, Musarat Jabeen, Ali Ahmed iD

Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026

DOI: 10.1177/23259582261452317 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), 2026. Verfasst von Muhammad Wasay Shahid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: HIV Infections, Health Personnel, Anti-HIV Agents, Anti-Retroviral Agents. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long-acting injectable antiretroviral therapy (LAI-ART), especially cabotegravir plus rilpivirine, is primarily recommended as a switch option for virally suppressed individuals and may improve adherence, privacy, and treatment satisfaction. Contemporary international guidance notes a restricted, closely monitored role for selected viraemic patients with persistent adherence challenges. Feasibility in low-resource systems remains uncertain. We explored perceived feasibility and acceptability of LAI-ART among HIV care providers and regulatory stakeholders in Pakistan.

Methods

We conducted semistructured in-depth interviews with 17 providers and stakeholders from ART centers, tertiary hospitals, the National AIDS Control Program, and a community-based organization in Islamabad and Rawalpindi. Interviews were audio recorded, transcribed, translated, and analyzed using reflexive thematic analysis.

Results

Participants viewed LAI-ART as promising for improving adherence, treatment fatigue, confidentiality, and workflow. Barriers included travel distance, needle phobia, missed dose risks, staffing constraints, cold chain and storage needs, infrastructure limitations, and weak biomedical waste management.

Conclusion

Stakeholders expressed cautious interest in LAI-ART while highlighting significant structural, financial, and sociocultural barriers. Participants emphasized that phased pilot implementation, sustainable financing, cultural acceptability, integration into differentiated service delivery, and stronger counselling and digital support would be necessary to support future introduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHealth PersonnelAnti-HIV AgentsAnti-Retroviral AgentsHumansPakistanQualitative ResearchFemaleMaleFeasibility StudiesAdultRilpivirineMedication AdherencePyridonesDiketopiperazines

Stichwörter der Autor:innen

HIV/AIDSLA-CAB/RPVPLHIVPakistanantiretroviral therapycabotegravir-rilpivirinefeasibility and acceptabilitylong-acting injectables. LAI-ARTpeople living with HIV

Substanzen

Anti-HIV AgentsRilpivirinecabotegravirAnti-Retroviral AgentsPyridonesDiketopiperazines

Autor:innen und Institutionen

  • Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
  • Al-Hamad Pharmacy, Islamabad, Pakistan.
  • National AIDS Control Program, Common Management Unit, Islamabad, Pakistan.
  • Department of Infectious Diseases, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Antiretroviral Therapy Centre, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, California, USA.

ORCID-Profile: Muhammad Wasay Shahid, Faizur Rehman, Mehran Riaz, Farah Azhar, Malik Muhammad Umair, Nasim Akhtar, Ali Ahmed

Zitieren

APA

Shahid, M. W., Rehman, F., Riaz, M., Akram, M. A., Azhar, F., Umair, M. M., Akhtar, N., Jabeen, M., & Ahmed, A. (2026). Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders. Journal of the International Association of Providers of AIDS Care (JIAPAC). https://doi.org/10.1177/23259582261452317

Vancouver

Shahid MW, Rehman F, Riaz M, Akram MA, Azhar F, Umair MM, et al. Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026. doi:10.1177/23259582261452317

BibTeX
@article{Shahid2026,
  author = {Shahid, Muhammad Wasay and Rehman, Faizur and Riaz, Mehran and Akram, Muhammad Aaqib and Azhar, Farah and Umair, Malik Muhammad and Akhtar, Nasim and Jabeen, Musarat and Ahmed, Ali},
  title = {Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders},
  journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
  year = {2026},
  doi = {10.1177/23259582261452317}
}
Kostenlos starten →